News

Filter

Current filters:

DiovanMarkets & Marketing

Takeda's Edarbi set to be gold standard for hypertension

06-03-2012

Based on clinical data and the opinions of interviewed thought leaders, Edarbi (azilsartan medoxomil),…

Cardio-vascularDiovanEdarbiGlobalMarkets & MarketingNovartisPharmaceuticalTakeda Pharmaceuticals

Actavis debuts generic Diovan in major European markets

20-11-2011

Iceland-headquartered generic drug major Actavis Group revealed on Friday that it has launched Valsartan…

ActavisCardio-vascularDiovanDiovan HCTEuropeGenericsMarkets & MarketingNovartisvalsartan

Fixed-dose combo of telmisartan/amlodipine “will become clinical gold standard for hypertension” in 2013

08-01-2010

A hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would…

Cardio-vascularDiovanEuropeMarkets & MarketingMicardisNorth AmericaNovartisPharmaceuticalTelmisartanvalsartan

Malaysian govt encouraging biotech sector of pharma market

22-10-2009

In the Business Environment Rating (BER) matrix for the fourth quarter of 2009, Malaysia has considerably…

Asia-PacificAvaproBiotechnologyCozaarDiovanGeneralGenericsirbesartanLosartan PotassiumMarkets & MarketingMerck KGaAMicardisPharmaceuticalPoliticsTelmisartanvalsartan

Back to top